Latest news
Combination therapy overcomes ferroptosis resistance in β-catenin-mutant hepatocellular carcinoma - News-MedicalNews-Medical · Sat, 08 Aug 2026 01:46:00 GMTFrom competitors to collaborators: How oncology brands are working together to market combination therapies - Medical Marketing and MediaMedical Marketing and Media · Fri, 07 Aug 2026 17:03:29 GMTTargeting the 4EBP1/HSP90β/Nrf2 axis sensitizes β-catenin-mutant hepatocellular carcinoma to mTOR inhibitors via ferroptosis induction - eurekalert.orgeurekalert.org · Fri, 07 Aug 2026 15:36:05 GMTMalaria Therapeutics Market Size And Share Report, 2033 - Grand View ResearchGrand View Research · Fri, 07 Aug 2026 11:12:02 GMTFerroptosis-based therapy shows promise for advanced prostate cancer treatment - News-MedicalNews-Medical · Fri, 07 Aug 2026 01:52:00 GMTEarly Treatment Is Key to Preventing Acne Scarring - EMJEMJ · Thu, 06 Aug 2026 21:26:43 GMTRisk Stratification and Treatment Selection in EGFR-Mutant NSCLC - OncLiveOncLive · Thu, 06 Aug 2026 19:45:26 GMTNew Combination Therapy Shows Promise for Advanced Bladder Cancer - CU Anschutz newsroomCU Anschutz newsroom · Thu, 06 Aug 2026 19:16:18 GMT